U-Neuron Biomedical (ROCO:6973) Treasury Stock: NT$-37.79 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
10 GF Score
Price NT$37.10
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical Treasury Stock?

U-Neuron Biomedical ROCO:6973 +0.82% 10 Treasury Stock is NT$-37.79 Mil as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 10/100. The stock has 2 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. U-Neuron Biomedical's treasury stock for the quarter that ended in Dec. 2025 was NT$-37.79 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


U-Neuron Biomedical Treasury Stock Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Treasury Stock Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -37.79

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -37.79 -37.79
ROCO:6973
10GF Score
U-Neuron Biomedical Inc ROCO:6973
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of NT$-37.79 Mil mean?
U-Neuron Biomedical (ROCO:6973) has a Treasury Stock of NT$-37.79 Mil as of Dec. 2025. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for U-Neuron Biomedical and its competitors.
Is U-Neuron Biomedical's Treasury Stock too high?
U-Neuron Biomedical's current Treasury Stock is NT$-37.79 Mil. Overall, U-Neuron Biomedical has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's Treasury Stock compare to VRTX and REGN?
U-Neuron Biomedical's Treasury Stock of NT$-37.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Biotechnology company?
A good Treasury Stock depends on the Biotechnology industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current Treasury Stock is NT$-37.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current Treasury Stock of NT$-37.79 Mil. The current Treasury Stock is NT$-37.79 Mil. U-Neuron Biomedical's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current Treasury Stock is NT$-37.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
10GF Score

Get the complete analysis for ROCO:6973

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$37.10
Price